Exchange: NASDAQ·Updated 06:20 AM EDT

JATT News

News
all
press releases
Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases
Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business...
PR Newswire

Advertisement|Remove ads.